SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Milk who wrote (293)7/16/1998 9:48:00 AM
From: Milk  Read Replies (1) of 369
 
UroMed Corporation Announces Second-Quarter Results:

biz.yahoo.com

NEEDHAM, Mass., July 16 /PRNewswire/ -- UroMed Corporation (Nasdaq: URMD - news) today reported revenues of $0.12 million for the second quarter ended June 30, 1998, compared with $0.2 million for the same period of 1997. UroMed reported a second-quarter 1998 net loss of $4.6 million, or $0.85 per share, compared with a net loss of $9.3 million, or $1.75 per share, for the comparable period of 1997. The company ended the second quarter of 1998 with cash, cash equivalents and short-term investments totaling $53.3 million.

For the six months ended June 30, 1998, UroMed reported revenues of $0.18 million, compared with revenues of $0.42 million for the same period a year ago. Net loss for the first six months of 1998 was $11.7 million, or $2.17 per share, compared with $17.6 million, or $3.32 per share for the same period in the prior year.

...

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext